공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 색전요법 시장

Global Embolotherapy Market

리서치사 BCC Research
발행일 2021년 09월 상품 코드 1029577
페이지 정보 영문 98 Pages
가격
US $ 5,500 ₩ 6,586,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,903,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,484,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 11,381,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 색전요법 시장 Global Embolotherapy Market
발행일 : 2021년 09월 페이지 정보 : 영문 98 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 색전요법 시장 규모는 예측 기간 중 6.7%의 CAGR로 추이하며, 2021년 31억 달러에서 2026년에는 43억 달러 규모로 성장할 것으로 예측됩니다.

지역별로는 북미 지역이 기간중 7.9%로 추이하며, 2021년 11억 달러에서 2026년에는 16억 달러 규모로 성장할 전망입니다. 또한 유럽 지역은 7.1%의 CAGR로 추이하며, 2021년 9억 2370만 달러에서 2026년에는 13억 달러 규모로 성장할 것으로 예측됩니다.

세계의 색전요법 시장을 조사했으며, 색전요법의 개요, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모의 추이·예측, 제품·적응증·시술·최종사용자·지역별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약·하이라이트

제3장 색전요법의 개요

  • 색전제의 유형
  • 색전요법의 발전 경위
  • 색전술의 이점
  • 색전의 리스크

제4장 시장 역학

  • 시장 촉진요인
  • 시장 억제요인

제5장 시장 분석·예측 : 제품 유형별

  • 개요
  • 시장 분석
  • 시장 규모
  • 시장 점유율

제6장 시장 분석·예측 : 적응증별

  • 개요
  • 시장 분석
  • 시장 점유율

제7장 시장 분석·예측 : 시술별

  • 개요
  • 시장 분석
  • 시장 점유율

제8장 시장 분석·예측 : 최종사용자별

  • 개요
  • 시장 분석
  • 시장 점유율

제9장 시장 분석·예측 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제10장 경쟁 구도

  • M&A
  • 주요 개발
  • 기업 점유율 분석
  • COVID-19의 영향

제11장 기업 개요

  • ACANDIS GMBH
  • ABK BIOMEDICAL
  • BALT USA LLC
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL
  • GUERBET
  • JOHNSON & JOHNSON
  • KANEKA CORP.
  • MEDTRONIC PLC
  • MERIT MEDICAL SYSTEMS INC.
  • PENUMBRA INC.
  • SIRTEX MEDICAL INC.
  • STRYKER CORP.
  • TERUMO CORP.
KSA 21.10.13

List of Tables

  • Summary Table A : Global Market for Embolotherapy, Through 2026
  • Summary Table B : Global Market for Embolotherapy, by Region, Through 2026
  • Table 1 : Embolization Device Recalled by FDA, 2019 and 2020
  • Table 2 : Global Market for Embolotherapy, Through 2026
  • Table 3 : Global Market for Embolotherapy, by Product Type, Through 2026
  • Table 4 : Global Market for Embolotherapy, by Indication, Through 2026
  • Table 5 : Global Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 6 : Global Market for Embolotherapy, by End User, Through 2026
  • Table 7 : Global Market for Embolotherapy, by Region, Through 2026
  • Table 8 : North American Market for Embolotherapy, by Product Type, Through 2026
  • Table 9 : North American Market for Embolotherapy, by Indication, Through 2026
  • Table 10 : North American Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 11 : North American Market for Embolotherapy, by End User, Through 2026
  • Table 12 : European Market for Embolotherapy, by Product Type, Through 2026
  • Table 13 : European Market for Embolotherapy, by Indication, Through 2026
  • Table 14 : European Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 15 : European Market for Embolotherapy, by End User, Through 2026
  • Table 16 : APAC Market for Embolotherapy, by Product Type, Through 2026
  • Table 17 : APAC Market for Embolotherapy, by Indication, Through 2026
  • Table 18 : APAC Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 19 : APAC Market for Embolotherapy, by End User, Through 2026
  • Table 20 : RoW Market for Embolotherapy, by Product Type, Through 2026
  • Table 21 : RoW Market for Embolotherapy, by Indication, Through 2026
  • Table 22 : RoW Market for Embolotherapy, by Procedure Type, Through 2026
  • Table 23 : RoW Market for Embolotherapy, by End User, Through 2026
  • Table 24 : Boston Scientific Corp.: Business Segments
  • Table 25 : Boston Scientific Corp.: Product Portfolio
  • Table 26 : Boston Scientific Corp.: Financial Performance, 2016-2020
  • Table 27 : Cook Medical: Business Segments
  • Table 28 : Cook Medical: Product Portfolio
  • Table 29 : Johnson & Johnson: Business Segments
  • Table 30 : Johnson & Johnson: Product Portfolio
  • Table 31 : Johnson & Johnson: Financial Performance, 2018-2020
  • Table 32 : Medtronic Plc: Business Segments
  • Table 33 : Medtronic Plc: Product Portfolio
  • Table 34 : Medtronic Plc: Financial Performance, 2018-2020
  • Table 35 : Merit Medical Systems Inc.: Business Segments
  • Table 36 : Merit Medical Systems Inc.: Product Portfolio
  • Table 37 : Merit Medical Systems Inc.: Financial Performance, 2016-2020
  • Table 38 : Penumbra Inc: Business Segments
  • Table 39 : Penumbra Inc.: Product Portfolio
  • Table 40 : Penumbra: Financial Performance, 2018-2020
  • Table 41 : Stryker Corp.: Business Segments
  • Table 42 : Stryker Corp.: Product Portfolio
  • Table 43 : Stryker Corp.: Financial Performance, 2016-2020
  • Table 44 : Terumo Corp.: Business Segments
  • Table 45 : Terumo Corp.: Financial Performance, 2015-2019

List of Figures

  • Summary Figure A : Global Market for Embolotherapy, 2019-2026
  • Summary Figure B : Global Market for Embolotherapy, 2019-2026
  • Figure 1 : Types of Embolic Agents
  • Figure 2 : Global Market for Embolotherapy, 2019-2026
  • Figure 3 : Global Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 4 : Global Market Shares of Embolotherapy, by Product Type, 2020
  • Figure 5 : Global Market for Embolotherapy, by Indication, 2019-2026
  • Figure 6 : Global Market Shares of Embolotherapy, by Indication, 2020
  • Figure 7 : Global Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 8 : Global Market Shares of Embolotherapy, by Procedure Type, 2020
  • Figure 9 : Global Market for Embolotherapy, by End User, 2019-2026
  • Figure 10 : Global Market Shares of Embolotherapy, by End User, 2020
  • Figure 11 : Global Market for Embolotherapy, by Region, 2019-2026
  • Figure 12 : Global Market Shares of Embolotherapy, by Region, 2020
  • Figure 13 : North American Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 14 : North American Market for Embolotherapy, by Indication, 2019-2026
  • Figure 15 : North American Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 16 : North American Market for Embolotherapy, by End User, 2019-2026
  • Figure 17 : European Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 18 : European Market for Embolotherapy, by Indication, 2019-2026
  • Figure 19 : European Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 20 : European Market for Embolotherapy, by End User, 2019-2026
  • Figure 21 : APAC Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 22 : APAC Market for Embolotherapy, by Indication, 2019-2026
  • Figure 23 : APAC Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 24 : APAC Market for Embolotherapy, by End User, 2019-2026
  • Figure 25 : APAC Market for Embolotherapy, by End User, 2019-2026
  • Figure 26 : RoW Market for Embolotherapy, by Product Type, 2019-2026
  • Figure 27 : RoW Market for Embolotherapy, by Procedure Type, 2019-2026
  • Figure 28 : RoW Market for Embolotherapy, by End User, 2019-2026
  • Figure 29 : Global Company Market Shares of Embolotherapy, 2020
  • Figure 30 : Boston Scientific Corp.: Total Sales Share, by Business Segment, 2020
  • Figure 31 : Boston Scientific Corp.: Total Revenue Share, by Region, 2020
  • Figure 32 : Johnson & Johnson: Total Sales Share, by Business Segment, 2020
  • Figure 33 : Johnson & Johnson: Total Revenue Share, by Region, 2020
  • Figure 34 : Medtronic Plc: Total Sales Share, by Business Segment, 2020
  • Figure 35 : Medtronic Plc: Total Revenue Share, by Region, 2020
  • Figure 36 : Merit Medical Systems Inc.: Total Sales Share, by Business Segment, 2020
  • Figure 37 : Merit Medical Systems Inc.: Total Revenue Share, by Region, 2020
  • Figure 38 : Penumbra: Total Sales Share, by Business Segment, 2020
  • Figure 39 : Penumbra: Total Revenue Share, by Region, 2020
  • Figure 40 : Stryker Corp.: Total Sales Share, by Business Segment, 2020
  • Figure 41 : Stryker Corp.: Total Revenue Share, by Region, 2020
  • Figure 42 : Terumo Corp.: Total Sales Share, by Business Segment, 2019
  • Figure 43 : Terumo Corp.: Total Revenue Share, by Region, 2019

Highlights:

The global market for embolotherapy should grow from $3.1 billion in 2021 to $4.3 billion by 2026 with a compound annual growth rate (CAGR) of 6.7% for the period of 2021-2026.

North American embolotherapy market should grow from $1.1 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 7.9% for the period of 2021-2026.

European embolotherapy market should grow from $923.7 million in 2021 to $1.3 billion by 2026 with a compound annual growth rate (CAGR) of 7.1% for the period of 2021-2026.

Report Scope:

This report will focus on both embolic agents and support devices. These embolization devices are used across various indications such as in oncology, nephrology, neurology, urology and vascular diseases. The report also portrays the trends and dynamics affecting the market. The report also covers market projections to 2026, and it features company profiles. By geography, the market has been segmented into the following regions: North America, Europe, Asia-Pacific and Rest of the World. For market estimates, data has been provided for 2019 as the historic year, 2020 as the base year and 2021 as the estimation year; and market forecasts have been given for 2026.

Report Includes:

  • 31 data tables and 16 additional tables
  • An overview of the global embolotherapy market with focus on both embolic agents and support devices
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021, with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the market potential for embolotherapy, by type, indication, procedure, end user, and region
  • Detailed description of types, history, benefits, and risks associated with embolization and coverage of relationship between minimally invasive procedures and embolotherapy
  • Identification of market drivers, restraints and other forces impacting the market and analysis of the regulatory framework and product recalls of the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including Boston Scientific Corp., Johnson & Johnson, Medtronic Plc., Penumbra, Stryker Corp. and Terumo Corp.

Table of Contents

Chapter 1 Introduction

  • Introduction
  • Study Goals and Objectives
  • Scope of Report
  • Information Sources
  • Primary Research
  • Secondary Research
  • Research Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview of Embolotherapy

  • Overview
  • Types of Embolic Agents
  • Permanent Agents
  • Temporary Agents
  • History of Embolotherapy
  • Benefits of Embolization
  • Risks of Embolization

Chapter 4 Market Dynamics

  • Market Drivers
  • Increasing Demand for Minimally Invasive Procedures
  • Technological Advancements
  • Increasing Prevalence of Target Indications
  • Market Restraints
  • Lack of Skilled Interventional Radiologists
  • Complications Associated with Embolotherapy
  • Lack of Awareness
  • Market Recalls

Chapter 5 Market Breakdown by Product Type

  • Overview
  • Market Analysis
  • Global Market for Embolotherapy by Product Type
  • Global Market Shares of Embolotherapy by Product Type

Chapter 6 Market Breakdown by Indication

  • Overview
  • Market Analysis
  • Global Market Shares of Embolotherapy by Indication

Chapter 7 Market Breakdown by Procedure

  • Overview
  • Market Analysis
  • Global Market Shares of Embolotherapy by Procedure Type

Chapter 8 Market Breakdown by End-User

  • Overview
  • Market Analysis
  • Global Market Shares of Embolotherapy by End User Type

Chapter 9 Market Breakdown by Region

  • Overview
  • Global Market for Embolotherapy by Region
  • North American Market for Embolotherapy
  • North American Market for Embolotherapy by Product Type
  • North American Market for Embolotherapy by Indication
  • North American Market for Embolotherapy by Procedure Type
  • North American Market for Embolotherapy by End User
  • European Market for Embolotherapy
  • European Market for Embolotherapy by Product Type
  • European Market for Embolotherapy by Indication
  • European Market for Embolotherapy by Procedure Type
  • European Market for Embolotherapy by End User
  • Asia-Pacific (APAC) Market for Embolotherapy
  • APAC Market for Embolotherapy by Product Type
  • APAC Market for Embolotherapy by Indication
  • APAC Market for Embolotherapy by Procedure Type
  • APAC Market for Embolotherapy by End User
  • Rest of the World (RoW) Market for Embolotherapy
  • RoW Market for Embolotherapy by Product Type
  • RoW Market for Embolotherapy by Indication
  • RoW Market for Embolotherapy by Procedure Type
  • RoW Market for Embolotherapy by End User

Chapter 10 Competitive Landscape

  • Mergers and Acquisitions
  • Key Developments
  • Global Company Share Analysis
  • Impact of COVID-19 on the Embolotherapy Market

Chapter 11 Company Profiles

  • ACANDIS GMBH
  • ABK BIOMEDICAL
  • BALT USA LLC
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL
  • GUERBET
  • JOHNSON & JOHNSON
  • KANEKA CORP.
  • MEDTRONIC PLC
  • MERIT MEDICAL SYSTEMS INC.
  • PENUMBRA INC.
  • SIRTEX MEDICAL INC.
  • STRYKER CORP.
  • TERUMO CORP.
Back to Top
전화 문의
F A Q